RxDoctor Payments DataLook up a doctor →

Seema Dixit, DO

Neurology · Somerset, NJNPI 1144476417

Payments from drug & device makers

$81,399in general payments, 2019–2025

Across 2,022 payments — averaging $40.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$39K
  • Axsome Therapeutics, Inc.$9K
  • UCB, Inc.$9K
  • Novartis$3K
  • Supernus Pharmaceuticals, Inc.$2K
  • Biogen$2K
  • plus $17K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)279$39,076
Axsome Therapeutics, Inc.18$9,211
UCB, Inc.124$8,592
Novartis273$3,264
Supernus Pharmaceuticals, Inc.53$2,132
Biogen83$1,770
Teva Pharmaceuticals USA, Inc.124$1,536
Lilly USA, LLC94$1,217
Eisai Inc.75$1,039
Biohaven Pharmaceuticals, Inc.50$915
EMD Serono, Inc.53$836
SK Life Science, Inc.49$823
Argenx US, Inc.50$753
Bristol Myers Squibb44$573
Amgen(2 entities)43$514
Neurelis, Inc.34$507
Sunovion Pharmaceuticals Inc.30$491
AstraZeneca(2 entities)33$481
Lundbeck LLC32$466
Pfizer34$411
Kyowa Kirin, Inc.23$410
Neurocrine Biosciences, Inc.32$400
Biohaven Pharmaceutical Holding Company Ltd.37$386
Genentech USA, Inc.24$356
Amneal Pharmaceuticals LLC22$329
Scilex Pharmaceuticals Inc.21$318
Impel Pharmaceuticals Inc.20$314
Johnson & Johnson26$298
Sumitomo Pharma America, Inc.17$261
Acadia Pharmaceuticals Inc27$259
Sanofi9$239
Idorsia Pharmaceuticals US Inc17$234
Livanova USA, Inc.3$179
CSL Behring11$176
Jazz Pharmaceuticals Inc.10$165
E.r. Squibb & Sons, L.L.C.4$163
Otsuka America Pharmaceutical, Inc.10$162
Upsher-smith Laboratories LLC11$161
Grifols USA, LLC6$104
Bausch Health US, LLC7$102
Boston Scientific5$98
Aquestive Therapeutics, Inc.7$97
Aucta Pharmaceuticals, Inc.10$95
Merz Pharmaceuticals, LLC5$93
Arbor Pharmaceuticals, Inc.6$88
Greenwich Biosciences, Inc.3$82
Medtronic(2 entities)3$82
Abbott2$77
Aprecia Pharmaceuticals, LLC5$69
Assertio Therapeutics, Inc.5$69
Avion Pharmaceuticals4$66
Corium, LLC5$63
Octapharma USA, Inc.4$61
Acorda Therapeutics, Inc4$59
Mallinckrodt Hospital Products Inc.4$57
Almatica Pharma LLC4$55
Merck4$52
Vanda Pharmaceuticals Inc.3$49
Merz North America, Inc.2$49
Adamas Pharmaceuticals, Inc.3$49

How this compares

$81,399 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$383,012
Medicare patients
976
Services billed
6,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Somerset

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →